Objective: Lactational mastitis can
progress to local abscess formation if not treated promptly. The study aims to understand whether the
use of intravenous cephalosporin plus clindamycin could reduce breast abscess
formation when preferred as a first-line treatment instead of oral penicillin.
Method: Patients who admitted to our
outpatient clinic with sign and symptoms of lactational mastitis were recruited
retrospectively for the study. Patients who had abscess formation on admittance
were excluded. Patients were categorized into two groups according to
antibiotic preference as the group I with intravenous ceftriaxone plus
clindamycin and group II with oral penicillin. Groups were compared according
to abscess formation in follow-up by physical examination and ultrasound.
Results: A
total of 64 patients with severe lactational mastitis were included. In group I
(n=29), only one breast abscess with MSSA was developed. However, seven cases
of breast abscess were developed in the second group (n=35). MRSA (n=4), MSSA
(n=1), gram-negative bacilli (n=1) and no organism (n=1) were cultured in pus
among group II. The prevalence of abscess in group I is found to be
significantly lower in comparison to the control group in 12 weeks follow-up
(p=0.049).
Conclusions: MRSA
and gr (-) bacilli are the significant agents in persistent breast abscess
formation, which are resistant to oral penicillin or first/second-line
cephalosporin. The ceftriaxone plus clindamycin could be used to reduce abscess
formation after severe lactational mastitis, therefore, avoids unnecessary
operations and hospitalization.
Primary Language | English |
---|---|
Subjects | Health Care Administration |
Journal Section | Surgical Science Research Articles |
Authors | |
Publication Date | September 30, 2019 |
Acceptance Date | September 25, 2019 |
Published in Issue | Year 2019Volume: 41 Issue: 3 |